Mesoblast (MESO) Total Liabilities (2015 - 2025)

Mesoblast has disclosed Total Liabilities across 11 years of filings, most recently posting $207.6 million for Q4 2025.

• Total Liabilities for Q4 2025 came in at $207.6 million, up 8.11% year-over-year; the trailing twelve-month figure through Dec 2025 was $207.6 million (up 8.11% YoY), and the FY2025 annual result was $187.2 million, down 0.82% from the prior year.
• Total Liabilities came in at $207.6 million for Q4 2025 at Mesoblast, up from $187.2 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $207.6 million in Q4 2025 to a low of $161.6 million in Q4 2023.
• The 5-year median for Total Liabilities is $167.6 million (2023), against an average of $172.8 million.
• Across the five-year window, Total Liabilities fell 11.37% in 2021 and advanced 18.88% in 2024, its largest moves.
• Mesoblast's Total Liabilities stood at $168.9 million in 2021, then fell by 0.52% to $168.1 million in 2022, then retreated by 3.87% to $161.6 million in 2023, then rose by 18.88% to $192.1 million in 2024, then increased by 8.11% to $207.6 million in 2025.
• The last three Total Liabilities figures came in at $207.6 million (Q4 2025), $187.2 million (Q2 2025), and $192.1 million (Q4 2024), per Business Quant data.